Monica Jimenez-Carretero

Ms. Monica Jimenez-Carretero

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

Verified
Journal Article
Open access
PDF file
MDMarta Donini
Marta Donini
FPFrancesca Pettinella
Francesca Pettinella
GZGiorgia Zanella
Giorgia Zanella
SGSalvatore Calogero Gaglio
Salvatore Calogero Gaglio
CLCarlo Laudanna
Carlo Laudanna
SDStefano Dusi
Stefano Dusi
The use of nanoparticles in medicine is sometimes hampered by their potential to activate immune cells, eliciting inflammation or allergy. We investigated whether magnetic nanoparticles (MNPs) or biomimetic magnetic nanoparticles (BMNPs) affect relevant activities of human monocytes. We found that the nanoparticles neither elicited the production of pro-inflammatory mediators IL-6 and TNFα by resting monocytes (when BMNP dose < 300 μg/mL) nor enhanced their secretion induced by R848, a molecule engaging virus-recognizing receptors, or bacterial lipopolysaccharide (LPS). MNPs and BMNPs neither induced the generation of reactive oxygen species (ROS), nor affected the ROS production elicited by the NADPH oxidase activator phorbol myristate acetate (PMA) or the fungal derivative β-glucan. BMNPs, but not MNPs, caused an up-regulation of the maturation markers CD80, CD83, and CD86 in immature monocyte-derived dendritic cells (DCs), whereas both nanoparticles did not affect the LPS-induced expression of these markers. Moreover, the nanoparticles were greedily ingested by monocytes and DCs without altering their viability. Therefore, these nanoparticles are candidates for medical applications because they do not activate pro-inflammatory activities of monocytes. Furthermore, their ability to stimulate DC maturation could be used for the design of vaccines. Moreover, harmlessly engulfed nanoparticles could be vehicles to carry molecules inside the immune cells to regulate the immune response.

12 January 2023 in Food Control
Verified
Journal Article
Closed access
MJMonica Jimenez-Carretero
Monica Jimenez-Carretero
JRJavier Rodríguez-López
Javier Rodríguez-López
CRCristina Ropero-Moreno
Cristina Ropero-Moreno
JGJuan Granada
Juan Granada
JMJosemaría Delgado Martín
Josemaría Delgado Martín
Concepción Jimenez-LopezConcepción Jimenez-Lopez
Concepción Jimenez-Lopez

3 August 2024 in Bioorganic Chemistry
Verified
Journal Article
Open access
ASAlberto Sola-Leyva
Alberto Sola-Leyva
YJYlenia Jabalera
Ylenia Jabalera
MJMonica Jimenez-Carretero
Monica Jimenez-Carretero
MLMarina Lázaro
Marina Lázaro
TPTamara Pozo-Gualda
Tamara Pozo-Gualda
Concepción Jimenez-LopezConcepción Jimenez-Lopez
Concepción Jimenez-Lopez
Targeting phospholipid biosynthesis, specifically phosphatidylcholine (PC), which is enhanced in tumor cells, has been proven a suitable antitumor strategy. In fact, the overexpression of the choline kinase α1 (ChoKα1) isoform has been found in malignant cells and tumors, thus becoming an excellent antitumor target. ChoKα1 inhibitors are being synthesized at the present that show a large inhibitory activity. Two of them have been chosen in this study as representatives of different structural families: a biscationic biphenyl derivative of thieno[3,2-d]pyrimidinium substituted with a cyclic amine (here referred to as Fa22) and a biscationic biphenyl thioethano derivative of 7-chloro-quinolinium substituted with a pyrrolidinic moiety (here referred to as PL48). However, the potential use of these types of compounds in systemic treatments is hampered because of their low specificity. In fact, to enter the cell and reach their target, these inhibitors use choline transporters and inhibit choline uptake, being that one of the causes of their toxicity. One way to solve this problem could be allowing their entrance into the cells by alternative ways. With this goal, MamC-mediated magnetic nanoparticles (BMNPs), already proven effective drug nanocarriers, have been used to immobilize Fa22 and PL48. The idea is to let BMNPs enter the cell (they enter the cell by endocytosis) carrying these molecules, and, therefore, offering another way in for these compounds. In the present study, we demonstrate that the coupling of Fa22 and PL48 to BMNPs allows these molecules to enter the tumoral cell without completely inhibiting choline uptake, so, therefore, the use of Fa22 and PL48 in these nanoformulations reduces the toxicity compared to that of the soluble drugs. Moreover, the nanoassemblies Fa22-BMNPs and PL48-BMNPs allow the combination of chemotherapy and local hyperthermia therapies for a enhanced cytotoxic effect on the tumoral HepG2 cell line. The consistency of the results, independently of the drug structure, may indicate that this behavior could be extended to other ChoKα1 inhibitors, opening up a possibility for their potential use in clinics.

20 May 2026 in ACS Omega
Verified
Journal Article
Open access
TPTamara Pozo-Gualda
Tamara Pozo-Gualda
MJMonica Jimenez-Carretero
Monica Jimenez-Carretero
PRPablo A. Rodriguez-Jimenez
Pablo A. Rodriguez-Jimenez
MBMiguel Burgos-Ruiz
Miguel Burgos-Ruiz
Concepción Jimenez-LopezConcepción Jimenez-Lopez
Concepción Jimenez-Lopez
Alejandro Rodriguez-NavarroAlejandro Rodriguez-Navarro
Alejandro Rodriguez-Navarro
Two types of bone tissue from laying hens─cortical and medullary bone─were selected to investigate how differences in structure, organization, organic matrix composition, mineral properties, and functionality, further potentiated following upon a thermal treatment (up to 800 °C), influence mineral reactivity, dissolution, and adsorption behavior, using Pb as a model adsorbate. At lower temperatures (600 °C), sintering promotes the coarsening of apatite crystals, leading to a reduction in surface area. Simultaneously, the loss of organic matter and the diffusion of foreign ions (e.g., Mg and Na) from the apatite lattice to the crystal surface alter both surface chemistry and charge. Bone mineral solubility and adsorption were strongly influenced by both bone type and treatment temperature. Medullary bone exhibited significantly higher solubility than cortical bone, particularly at intermediate treatment temperatures. This behavior appears to be primarily controlled by the organic matrix (e.g., collagen and proteoglycans) and the manner in which these components interact with or adsorb onto crystal surfaces. Pb adsorption was governed by both surface area and chemical composition, and predominantly occurred via a coupled dissolution–precipitation mechanism. Specifically, the dissolution of Ca-apatite was accompanied by the formation of highly insoluble Pb-bearing mineral phases at the bone surface. This process was notably more efficient in thermally treated medullary bone. Overall, this study demonstrates how key bone properties can be tailored for specific applications, highlighting the potential for revalorizing bone waste from the meat industry.